Skip to content

Evaluation of the Adjuvant Therapeutic Effect of Postbiotics on Chronic Periodontitis

Evaluation of the Adjuvant Therapeutic Effect of Postbiotics on Chronic Periodontitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094908
Enrollment
Unknown
Registered
2024-12-30
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic periodontitis (CP)

Interventions

Periodontal Basic Therapy Augmented with a Placebo Control Group:After brushing teeth in the morning and evening, rinse the mouth with a placebo solution.
Periodontal Basic Therapy Coupled with Probiotic Mouthwash Group:After completing dental cleansing in the morning and evening, utilize a postbiotic-infused oral rinsing solution for mouthwash.

Sponsors

Affiliated Stomatological Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Conforming to the Diagnostic Criteria for Chronic Periodontitis: A probing depth (PD) of >=4mm, clinical attachment loss (CAL) of >=2mm, and a positive result for bleeding on probing (BOP). 2. Individuals aged 18 to 60 years inclusive, of either sex. 3. With a minimum of twenty natural teeth retained in the oral cavity. 4. Having not undergone any recent comprehensive periodontal therapy; 5. The clinical records are comprehensive and intact, with no reported instances of food allergies or intolerances, and the individual has passed the medical examination with satisfactory results. 6. Exhibiting normal cognitive functioning, demonstrating robust adherence, possessing a comprehensive understanding of the trial, and voluntarily executing the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Coexisting with malignant neoplasms, autoimmune disorders, hematological conditions, and compromised hepatic and renal functionalities. 2.Afflicted with systemic conditions including hypertension, cardiovascular disease, and diabetes mellitus, among others. 3.Having undergone antibiotic therapy within the preceding month or with a necessity for antibiotic administration during the course of the study, and having participated in any clinical trials within the last 30 days. 4.Female individuals who are in the stages of gestation and lactation; 5.Presenting with malocclusion or suffering from occlusal trauma.

Design outcomes

Primary

MeasureTime frame
Probing Depth(PD);Clinical Attachment Level (CAL);

Secondary

MeasureTime frame
Gingival Index;Bleeding on Probing (BOP);Plaque Index;

Countries

China

Contacts

Public ContactYang Juanxia

Affiliated Stomatological Hospital of Nanchang University

417762412@qq.com+86 15970497048

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026